Evaluation of BF performance and new applications by the Scientific Advisory Board
BF Scientific Advisory Board (SAB) visited Helsinki on June 10-11, 2013 and evaluated the overall performance of BF in 2010-2012 and applications for support for bioscience technology platforms in 2014-2016. SAB will also make a statement on the BF Director candidates.
BF Board will discuss the outcome and consequences of the SAB evaluation on Friday June 28, 2013 after which the technology platforms and applicants will be provided with more information.
Composition of BF Scientific Advisory Board:
Chair: Carl-Henrik Heldin, Ludwig Institute for Cancer Research, Uppsala
Vice-Chair: Ole Petter Ottersen, University of Oslo
Members: Marja Jäättelä, Institute of Cancer Biology, Copenhagen
Gunnar von Heijne, Stockholm University
Matthias Wilmanns, EMBL, Hamburg